Truvian raises $105M, plans to submit benchtop blood-testing tech to FDA
Benchtop blood testing startup Truvian raised $105 million in series C funding, which it plans to use to pave the way to submit its device for FDA clearance.
Truvian Sciences raises $27.1M for a testing system needing only “a small sample of blood”
Truvian Sciences uses 7 drops of blood to produce lab accurate results in 20 minutes for a full suite of health tests but it has competitors both at home and abroad as it seeks to take on traditional lab testing providers like Quest Diagnostics and LabCorp.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Lawyers for Theranos’ Elizabeth Holmes get delay in trial date
Various news outlets reported that attorneys for Holmes successfully convinced a federal judge to delay setting a trial date in order to get more time to review some 20 million pages of documents.
HBO documentary ‘The Inventor’ goes inside the rise and fall of Theranos
Despite a couple of flaws, Alex Gibney's new film - airing March 18 - expertly portrays how Elizabeth Holmes's dream of changing the world of lab testing became a fraud.
Genalyte is taking the single fingertip blood test to the next level (yet another Theranos competitor)
Here's a look at a company that could seriously be in the running for Theranos' biggest competitor.
Theranos will “absolutely” get FDA approval and does not need more capital
Elizabeth Holmes has no doubt that Theranos will continue moving forward, despite public criticism.
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.